FIELD: medicine; may be used as stimulator of B-system immunity. SUBSTANCE: invention involves application, as stimulator of immunity B-system, compound 1-hydroxyhermatran (monohydrate). Proposed compound promotes synthesis of IgG, IgA, IgM immunoglobulins and intensifies synthesis of IgE. EFFECT: higher efficiency. 11 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF CHILDREN ILL WITH NEURODERMATITIS | 0 |
|
SU1608584A1 |
MEDICATION POSSESSING IMMUNOSTIMULATING AND HEMOSTIMULATING ACTION | 2009 |
|
RU2414223C1 |
METHOD FOR PREVENTION OF DYSPEPSIA AND CORRECTION OF IMMUNE HOMEOSTASIS IN NEWBORN CALVES | 2017 |
|
RU2661598C1 |
METHOD FOR EVALUATING OZONE THERAPY EFFECTIVENESS IN PATIENTS POSSESSING CHELICOBACTER DISEASE | 1999 |
|
RU2155344C1 |
IMMUNOSTIMULATING DRUG | 2012 |
|
RU2510277C1 |
METHOD FOR EVALUATION OF SPECIFIC ACTIVITY OF IMMUNE PREPARATIONS | 2005 |
|
RU2291425C1 |
ANTI-ENTEROVIRAL AND IMMUNOSTIMULATING AGENT | 2014 |
|
RU2554761C1 |
METHOD OF IMMUNOTHERAPY OF PURULENT RHINOSINUSITIS | 2010 |
|
RU2457789C2 |
PHARMACEUTICAL COMPOSITION FOR IMMUNE DISEASE TREATMENT | 2000 |
|
RU2203682C2 |
METHOD FOR ACCOMPANYING TREATMENT OF LYMPHOBLAST LEUCOSIS | 2006 |
|
RU2320367C1 |
Authors
Dates
1998-04-10—Published
1995-06-26—Filed